1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 1: 
Demographic and Clinical Data Regarding the Patients With and Without Microhemorrhages
VariablesPatients with Microhemorrhages (n = 197)Patients without Microhemorrhages (n = 1822)P Value
Age (years)67.2 ± 11.155.5 ± 15.9<.00001
Sex, male1131028.93
Hypertension156 (79.1%)545 (29.9%)<.00001
Diabetes mellitus56 (28.4%)289 (15.9%).00002
Brain stroke history
 Hemorrhage49 (24.9%)20 (1.1%)<.00001
 Infarction67 (34.0%)165 (9.1%)<.00001
White matter  hyperintensity<.00001
 Absent41 (20.8%)1387 (76.1%)
 Punctate foci64 (32.5%)289 (15.9%)
 Early confluent70 (35.5%)129 (7.1%)
 Confluent22 (11.2%)17 (0.9%)